[This corrects the article DOI: 10.1016/j.bbrep.2020.100726.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767797 | PMC |
| http://dx.doi.org/10.1016/j.bbrep.2020.100797 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Corrigendum to "Cabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase II Trial" [Eur. Urol. 86(2) (2024) 90-94].
Eur Urol
January 2025
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address:
Corrigendum to "Transcatheter arterial chemoembolisation combined with lenvatinib and cabozantinib in the treatment of advanced hepatocellular carcinoma" [Int. Immunopharmacol. 130 (2024) 111510].
Int Immunopharmacol
August 2024
Department of Hepatobiliary Surgery, Dazhou Central Hospital, Dazhou 635000, China. Electronic address:
Corrigendum: Impressive reduction of brain metastasis radionecrosis after cabozantinib therapy in metastatic renal carcinoma: a case report and review of the literature.
Front Oncol
September 2023
Radiotherapy Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
[This corrects the article DOI: 10.3389/fonc.2023.
View Article and Find Full Text PDFCorrigendum to "Cabozantinib inhibits AXL- and MET-dependent cancer cell migration induced by growth-arrest-specific 6 and hepatocyte growth factor" [Biochem. Biophys. Rep. 21 (2020) 100726].
Biochem Biophys Rep
December 2020
Department of Japan Medical Affairs, Japan Oncology Business Unit, Takeda Pharmaceutical Company Limited, 2-1-1 Nihonbashi-Honcho, Chuo-ku, Tokyo, 103-8668, Japan.
[This corrects the article DOI: 10.1016/j.bbrep.
View Article and Find Full Text PDFCorrigendum to 'Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update' [Eur J Cancer 94 (May 2018) 115-125].
Eur J Cancer
November 2018
Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!